| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |